Copeland Capital Management LLC Sells 44,754 Shares of U.S. Physical Therapy, Inc. $USPH

Copeland Capital Management LLC decreased its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 5.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 843,981 shares of the company’s stock after selling 44,754 shares during the quarter. U.S. Physical Therapy accounts for 1.5% of Copeland Capital Management LLC’s portfolio, making the stock its 13th largest position. Copeland Capital Management LLC owned about 5.55% of U.S. Physical Therapy worth $71,696,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in USPH. Cullen Frost Bankers Inc. lifted its position in U.S. Physical Therapy by 171.8% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock valued at $35,000 after acquiring an additional 280 shares in the last quarter. Parallel Advisors LLC raised its stake in shares of U.S. Physical Therapy by 90.6% in the second quarter. Parallel Advisors LLC now owns 448 shares of the company’s stock worth $35,000 after purchasing an additional 213 shares during the last quarter. Assetmark Inc. raised its stake in shares of U.S. Physical Therapy by 35.7% in the second quarter. Assetmark Inc. now owns 570 shares of the company’s stock worth $45,000 after purchasing an additional 150 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of U.S. Physical Therapy by 35.3% during the third quarter. Blue Trust Inc. now owns 640 shares of the company’s stock valued at $54,000 after purchasing an additional 167 shares in the last quarter. Finally, Huntington National Bank lifted its holdings in shares of U.S. Physical Therapy by 71.9% during the second quarter. Huntington National Bank now owns 667 shares of the company’s stock valued at $52,000 after purchasing an additional 279 shares in the last quarter.

U.S. Physical Therapy Price Performance

Shares of U.S. Physical Therapy stock opened at $81.49 on Tuesday. The stock’s fifty day moving average is $78.81 and its 200 day moving average is $80.31. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $93.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.20 and a current ratio of 1.20. The stock has a market cap of $1.24 billion, a P/E ratio of 34.24, a P/E/G ratio of 3.76 and a beta of 1.32.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. U.S. Physical Therapy had a return on equity of 8.62% and a net margin of 5.71%.The business had revenue of $140.66 million during the quarter. Sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, December 12th. Shareholders of record on Monday, November 17th were issued a dividend of $0.45 per share. The ex-dividend date of this dividend was Monday, November 17th. This represents a $1.80 annualized dividend and a yield of 2.2%. U.S. Physical Therapy’s payout ratio is currently 75.63%.

Analyst Ratings Changes

Several equities research analysts recently commented on USPH shares. JPMorgan Chase & Co. reduced their price objective on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Monday, November 24th. Barrington Research reiterated an “outperform” rating and issued a $103.00 price target on shares of U.S. Physical Therapy in a research note on Friday, October 24th. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a report on Monday, December 15th. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, October 8th. Finally, Wall Street Zen lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Sunday, September 21st. Four investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $105.33.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.